Lung Cancer Clinical Trial

Developing a Shared Decision Making Tool for Patients With Surgically Removed Non-small Cell Lung Cancer

Summary

This study observes conversations between non-small cell lung cancer patients and their doctors to support the development of a decision aid that can be used to inform discussions about treatment options for after surgery. Patients who have undergone surgery for their non-small cell lung cancer may have the option of completing additional treatment. Patients contemplating this additional treatment have been shown to be most satisfied with their choice if they perceive an effort by their doctor to share decision making. Shared decision making tools can help doctors guide conversations, offer tailored recommendations, and support deliberation on whether or not to pursue treatment. This study develops a shared decision making tool for patients with surgically removed non-small cell lung cancer contemplating additional treatment.

View Full Description

Full Description

PRIMARY OBJECTIVE:

I. To develop, in close collaboration with stakeholders, an evidence-based decision aid to inform discussions regarding options for adjuvant treatment in patients with resected non-small cell lung cancer (NSCL) (NSCL adjuvant choice).

OUTLINE:

Patient and clinician discussions are observed to support refinement of a decision aid. Clinicians may use a prototype of the decision aid in discussions with their patients and may complete a questionnaire.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

PATIENTS:
Adults >= 18 years with biopsy proven resected non-small cell lung cancer (NSCLC)
Appointments to discuss adjuvant treatment of resected NSCLC
CLINICIANS:
Clinicians who meet with patients to discuss adjuvant treatment of resected NSCLC
PAG MEMBERS:
Adults >= 18 years
Member of the Knowledge and Evaluation Research (KER) Unit Patient Advisory Group (PAG)

Exclusion Criteria:

PATIENTS
Major barriers to providing informed consent (i.e., dementia, severe hearing or visual impairment)

Study is for people with:

Lung Cancer

Estimated Enrollment:

100

Study ID:

NCT05416983

Recruitment Status:

Not yet recruiting

Sponsor:

Mayo Clinic

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Mayo Clinic in Rochester
Rochester Minnesota, 55905, United States More Info
Clinical Trials Referral Office
Contact
855-776-0015
[email protected]
Konstantinos Leventakos, M.D.
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

100

Study ID:

NCT05416983

Recruitment Status:

Not yet recruiting

Sponsor:


Mayo Clinic

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.